Rapport Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $5.2M | 166k | 31.29 |
| 2025-12-31 | $6.4M | 210k | 30.34 |
| 2025-09-30 | $8.2M | 275k | 29.70 |
| 2025-06-30 | $790k | 70k | 11.37 |
| 2024-12-31 | $400k | 23k | 17.67 |
| 2024-09-30 | $496k | 24k | 20.48 |